Deep Learning Unlocks Valuable Cancer Biology Clues
Dana-Farber Cancer Institute
AI models uncover patterns across two-dimensional images of tumor samples that could help predict response to immunotherapy
Immunohistochemistry
Is Immunohistochemistry an Assay Or a Stain?
Steven Bogen, MD, PhD
Interlaboratory inconsistency in IHC adversely affects the quality and standard of patient care
Recombinant, Universal MHC-I Molecules May Revolutionize Therapeutics
Swathi Kodaikal, MSc
Stable and compatible with a wide variety of HLA allotypes, pMHC-I molecules are a versatile immunotherapy tool
Immunolabeling New Biomarker May Help in Early Detection of Cervical Precancerous Lesions
Hefei Institutes of Physical Science
HMGB3 could effectively label the precancerous cells at different pathological stages
Artificial Intelligence Methods May Replace Histochemical Staining
Intelligent Computing
Improving pathology workflows using a new deep learning-based virtual staining framework
Polyclonal VHH Fragment Antibodies for Life Science R&D and Diagnostic Markets
Jackson ImmunoResearch
Secondary Antibodies for high-resolution imaging
Empowering Pathologists by Bringing Reference Standards to IHC
Steve Bogen, MD, PhD
The Consortium for Analytic Standardization in IHC is dedicated to improving IHC test accuracy and reproducibility